A multicenter, randomized, parallel controlled clinical trial to evaluate the safety and effectiveness of the endoscopic surgical system (KD-SR-01)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045983

Enrollment

Unknown

Registered

2021-05-01

Start date

2019-12-27

Completion date

Unknown

Last updated

2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urological Disease

Interventions

Group One:endoscopic surgical system(KD-SR-01)

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. The patients who need partial nephrectomy are in accordance with the indications; 2. Aged 18-75 years; 3. Those who agree to sign the informed consent, follow the doctor's advice and follow up regularly.

Exclusion criteria

Exclusion criteria: 1. Patients with severe uncontrolled disease or acute infection; 2. The patients with cardiovascular and cerebrovascular diseases, blood system diseases and diabetes can not be controlled and can not reach the operation standard; 3. Those who have immune system disease and can't control, can't reach the operation standard; 4. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
Surgical success rate;Surgical margin;Warm ischemia time;	—

Secondary

Measure	Time frame
Postoperative renal morphology;Operative complications;	—

Countries

China

Contacts

Public ContactZhou Liqun

Peking University First Hospital

zhoulqmail@sina.com+86 13601239241

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026